Citigroup Inc Nurix Therapeutics, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 49,593 shares of NRIX stock, worth $970,535. This represents 0.0% of its overall portfolio holdings.

Number of Shares

49,593

Previous 27,422 80.85%

Holding current value

$970,535

Previous $572,000 94.58%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$18.93 - $25.69 $419,697 - $569,572	22,171 Added 80.85%	49,593 $1.11 Million
Q2 2024 Aug 12, 2024	SELL	$12.02 - $21.3 $1.89 Million - $3.35 Million	-157,358 Reduced 85.16%	27,422 $572,000
Q1 2024 May 10, 2024	BUY	$7.77 - $15.66 $1.32 Million - $2.66 Million	169,635 Added 1120.07%	184,780 $2.72 Million
Q4 2023 Feb 09, 2024	SELL	$4.25 - $10.71 $114,983 - $289,759	-27,055 Reduced 64.11%	15,145 $156,000
Q3 2023 Nov 09, 2023	SELL	$7.86 - $10.08 $37,413 - $47,980	-4,760 Reduced 10.14%	42,200 $331,000
Q2 2023 Aug 10, 2023	SELL	$8.7 - $13.28 $575,452 - $878,392	-66,144 Reduced 58.48%	46,960 $469,000
Q1 2023 May 11, 2023	BUY	$8.56 - $13.26 $338,188 - $523,876	39,508 Added 53.68%	113,104 $1 Million
Q4 2022 Feb 09, 2023	SELL	$9.86 - $14.59 $462,650 - $684,591	-46,922 Reduced 38.93%	73,596 $808,000
Q3 2022 Nov 10, 2022	BUY	$12.33 - $19.81 $557,969 - $896,461	45,253 Added 60.12%	120,518 $1.57 Million
Q2 2022 Aug 10, 2022	BUY	$7.88 - $14.82 $394,669 - $742,259	50,085 Added 198.91%	75,265 $954,000
Q1 2022 May 12, 2022	SELL	$12.94 - $29.65 $665,517 - $1.52 Million	-51,431 Reduced 67.13%	25,180 $353,000
Q4 2021 Feb 10, 2022	SELL	$26.43 - $34.5 $1.16 Million - $1.52 Million	-44,041 Reduced 36.5%	76,611 $2.22 Million
Q3 2021 Nov 10, 2021	BUY	$22.71 - $36.69 $2.74 Million - $4.43 Million	120,652 New	120,652 $3.62 Million

Others Institutions Holding NRIX

# of Institutions

181

Shares Held

68.1M

Call Options Held

78K

Put Options Held

53.8K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $923M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account